AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report) was the target of a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 1,730,000 shares, a growth of 18.5% from the December 31st total of 1,460,000 shares. Based on an average trading volume of 583,400 shares, the […]
AngioDynamics (NASDAQ:ANGO – Free Report) had its price target cut by HC Wainwright from $20.00 to $18.00 in a research note released on Monday, Benzinga reports. They currently have a buy rating on the medical instruments supplier’s stock. HC Wainwright also issued estimates for AngioDynamics’ Q3 2024 earnings at ($0.12) EPS, Q4 2024 earnings at […]
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share guidance of -0.420–0.350 for the period, compared to the consensus earnings per share estimate of -0.320. The company issued revenue guidance of $320.0 million-$325.0 million, compared to the consensus revenue estimate of $329.1 million. AngioDynamics […]
AngioDynamics (NASDAQ:ANGO – Get Free Report) issued an update on its second quarter earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of ($0.05) for the period, compared to the consensus estimate of ($0.08). The company issued revenue guidance of $79.1 million, compared to the consensus revenue estimate of $81.95 million. […]
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Analysts at HC Wainwright reduced their Q2 2024 earnings estimates for shares of AngioDynamics in a research report issued to clients and investors on Thursday, October 5th. HC Wainwright analyst Y. Chen now anticipates that the medical instruments supplier will post earnings of ($0.08) per share for the […]